EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Anxiolytic and antidepressant potential of psychobiotics

Yuri A. Sergeev, Eduard V. Beyer, Igor A. Bazikov

Kazan medical journal · 28.07.2026 · 107 (4) · 598-614

DOI: 10.17816/kmj699666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kazan medical journal, online erschienen am 28.07.2026. Verfasst von Yuri A. Sergeev und 2 weiteren Autor:innen. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The problem of depression and anxiety disorders attracted widespread interest in the late 20th and early 21st centuries among both psychopharmacologists and psychiatrists and the general public. Interest in this topic grew substantially with the emergence of the gut–brain axis concept, which reflects the relationship between the microbiome and the functional activity of the central nervous system. Today, the study of this relationship is a complex interdisciplinary challenge that includes identifying risk factors for the development of anxiety and depressive disorders and finding ways to correct them. Of particular interest is the influence of the microbiome on the stabilization of central nervous system disorders. In this context, probiotics are considered a promising therapeutic approach due to their potential anxiolytic and antidepressant effects. This article summarizes data on the effects of probiotic bacterial strains on central nervous system metabolic processes, including neurotransmitter levels associated with the development of depression and anxiety. A search for scientific publications was conducted in the PubMed, eLibrary.Ru, Google Scholar, MEDLINE, and PMC databases for the period from 2008 to October 30, 2025. The review included experimental and clinical studies, including case–control studies, on methods for correcting depression and anxiety disorders using probiotic strains. The available data suggest that probiotics may represent a potential alternative pharmacological strategy for treating depressive and anxiety disorders.

Zitieren

APA

Sergeev, Y. A., Beyer, E. V., & Bazikov, I. A. (2026). Anxiolytic and antidepressant potential of psychobiotics. Kazan medical journal, 107(4), 598-614. https://doi.org/10.17816/kmj699666

Vancouver

Sergeev YA, Beyer EV, Bazikov IA. Anxiolytic and antidepressant potential of psychobiotics. Kazan medical journal. 2026;107(4):598-614. doi:10.17816/kmj699666

BibTeX
@article{Sergeev2026,
  author = {Sergeev, Yuri A. and Beyer, Eduard V. and Bazikov, Igor A.},
  title = {Anxiolytic and antidepressant potential of psychobiotics},
  journal = {Kazan medical journal},
  year = {2026},
  volume = {107},
  number = {4},
  pages = {598--614},
  doi = {10.17816/kmj699666}
}
Kostenlos starten →